We are live on ! Find out more
TWMP

Taylor Wealth Management Partners Portfolio holdings

AUM $176M
1-Year Est. Return 14.65%
This Fund
S&P 500
This Quarter Est. Return
-3.09%
1 Year Est. Return
-14.65%
3 Year Est. Return
+62.03%
5 Year Est. Return
+168.63%
10 Year Est. Return
AUM
$280M
AUM Growth
-$3.27M
Cap. Flow
+$10.7M
Cap. Flow %
3.81%
Top 10 Hldgs %
41.99%
Holding
74
New
6
Increased
34
Reduced
27
Closed
3

Top Buys

Rank Stock Value
1
LPX icon
Louisiana-Pacific
LPX
+$5.66M
2
MTZ icon
MasTec
MTZ
+$3.32M
3
TRIP icon
TripAdvisor
TRIP
+$2.54M
4
CRM icon
Salesforce
CRM
+$935K
5
JPM icon
JPMorgan Chase
JPM
+$713K

Sector Composition

Rank Sector Weight
1 Technology 31.69%
2 Financials 16.48%
3 Industrials 14.84%
4 Healthcare 14.54%
5 Consumer Discretionary 8.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TMO icon
51
Thermo Fisher Scientific
TMO
$216B
$684K 0.24%
1,197
+403
+51% +$221K
MMX
52
DELISTED
Maverix Metals Inc. Common Shares
MMX
$512K 0.18%
114,483
-30,602
-21% -$146K
GRTX
53
DELISTED
Galera Therapeutics, Inc. Common Stock
GRTX
$470K 0.17%
58,012
-7,180
-11% -$61.5K
GILD icon
54
Gilead Sciences
GILD
$164B
$420K 0.15%
6,013
+75
+1% +$5.27K
SYK icon
55
Stryker
SYK
$129B
$369K 0.13%
1,398
+20
+1% +$5.35K
DHR icon
56
Danaher
DHR
$142B
$346K 0.12%
1,284
+221
+21% +$60.2K
KRYS icon
57
Krystal Biotech
KRYS
$9.56B
$345K 0.12%
6,615
RCM
58
DELISTED
R1 RCM Inc. Common Stock
RCM
$339K 0.12%
15,400
+400
+3% +$8.27K
VRTX icon
59
Vertex Pharmaceuticals
VRTX
$124B
$313K 0.11%
1,723
+240
+16% +$46.9K
UNH icon
60
UnitedHealth
UNH
$369B
$312K 0.11%
799
+101
+14% +$41.8K
ZBH icon
61
Zimmer Biomet
ZBH
$18.3B
$263K 0.09%
1,853
IQV icon
62
IQVIA
IQV
$38.6B
$252K 0.09%
1,053
+216
+26% +$54.5K
MRK icon
63
Merck
MRK
$315B
$249K 0.09%
+3,314
New +$252K
BDX icon
64
Becton Dickinson
BDX
$48.6B
$241K 0.09%
1,006
+26
+3% +$6.38K
HQY icon
65
HealthEquity
HQY
$8.7B
$218K 0.08%
3,359
AMJ
66
DELISTED
JP Morgan Alerian MLP Index ETN 5/24/24
AMJ
$213K 0.08%
+11,700
New +$212K
VYNT
67
DELISTED
Vyant Bio, Inc. Common Stock
VYNT
$192K 0.07%
16,439
-685
-4% -$9.47K
CBAN icon
68
Colony Bankcorp
CBAN
$465M
$190K 0.07%
10,151
KALA icon
69
KALA BIO
KALA
$14.1M
$115K 0.04%
18
+1
+6% +$8.63K
PHGE icon
70
BiomX
PHGE
$1.71M
$78K 0.03%
134
-33
-20% -$25.6K
PHGE.WS
71
DELISTED
BiomX Inc. Warrants to purchase one-half of a share of Common Stock
PHGE.WS
$13K ﹤0.01%
40,098
-30
-0.1% -$11
AMGN icon
72
Amgen
AMGN
$220B
-862
Closed -$210K
OTRK
73
DELISTED
Ontrak
OTRK
-856
Closed -$2.5M
EVFM
74
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
-33,877
Closed -$574K

Similar funds

Taylor Wealth Management Partners's Q3 2021 Portfolio in Review

As of Q3 2021, Taylor Wealth Management Partners held 74 positions worth $280M, down 1.2% from $284M the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Taylor Wealth Management Partners deployed $10.7M of net new capital in Q3 2021, opening 6 new positions and adding to 34 existing holdings. Its largest new stake was Louisiana-Pacific: 96,038 shares worth $5.89M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 32% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Mercury Systems, an estimated $2.08M trimmed.

  • Taylor Wealth Management Partners's largest Q3 2021 buy was Louisiana-Pacific: 96,038 shares worth $5.89M.
  • Taylor Wealth Management Partners added most to JPMorgan Chase in Q3 2021, an estimated $713K increase.
  • Taylor Wealth Management Partners's biggest Q3 2021 reduction was Mercury Systems, cutting an estimated $2.08M.
  • Taylor Wealth Management Partners fully exited Ontrak in Q3 2021, selling an estimated $2.5M.
  • Taylor Wealth Management Partners's ten largest holdings make up 42% of its $280M portfolio in Q3 2021.
  • Taylor Wealth Management Partners opened 6 new positions and closed 3 in Q3 2021.
  • Taylor Wealth Management Partners's portfolio value fell 1.2% quarter-over-quarter to $280M.

Based on Taylor Wealth Management Partners's 13F filing for Q3 2021, filed 26 Oct 2021.